Incidence and Severity of Residual Neuromuscular Blockade

Completed · Phase 4

Conditions studied: Residual Neuromuscular Blockade

In brief

This prospective study will take place at Harborview Medical Center (HMC) and the University of Washington Medical Center (UWMC), and will enroll adult patients undergoing abdominal surgery. The purpose of this study is to identify if the use of a specific plan to managing muscle relaxants will help decrease the risk of muscle weakness after general anesthesia with muscle relaxation in a population of patients undergoing abdominal surgery.

Key facts

Study ID

NCT02660398

Run by

University of Washington

People needed

78

Starts

2016-01-01

Expected to finish

2017-01-01

Last updated by the study team

2019-05-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults age 18 or older
• Will undergo open or laparoscopic abdominal surgery expected to last <6 hours at HMC or UWMC
• Have ASA physical status I-III
• Scheduled to have general anesthesia with at least 1 dose of nondepolarizing NMBD for endotracheal intubation or maintenance of neuromuscular block (NMB)

You may not qualify if…

• Allergy to NMBDs
• Patients with neuromuscular disease (myasthenia gravis or muscular dystrophy)
• Pregnant or lactating women
• Non-English speaking
• Unable to provide informed consent

Where it is running

• University of Washington Medical Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.